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                                           ABSTRACT 
 
BACKGROUND 
 
 Many studies have been carried out till date that talk about severity of chronic 
periodontitis  but none correlates with Albumin level in blood before and after 
instituting phase I periodontal therapy. Since albumin is an important biomarker for 
systemic inflammation, it must be interesting to check whether periodontal health 
status has anything to do with the albumin level in blood. Hence, present study was 
carried out to determine albumin level in blood before and after instituting phase I 
periodontal therapy and to find out whether it has any effect on systemic health. 
   
AIM 
The aim of this study is to determine whether there is an alteration in the level 
of serum albumin in patients with chronic periodontitis before and after phase I 
therapy. 
METHODS  
  Fifteen   patients with chronic periodontitis and 15 systemically healthy 
subjects without periodontal disease were selected. Serum albumin levels in 
individuals with healthy periodontium (control group) and chronic periodontitis 
(study group) were compared. Serum albumin levels and clinical periodontal 
parameters (pocket depth, clinical attachment level, gingival index, bleeding index 
and plaque index) were measured at baseline and 3 months after non-surgical 
periodontal treatment in chronic periodontitis patients. Data were analyzed with 
descriptive statistical methods (means ± standard deviations). Independent samples t-
test was used to compare serum albumin levels and clinical variables between the test 
and control groups. Paired samples t-test was used in the test group for comparisons 
before and after treatment. Statistical significance was set at P < 0.05. 
RESULTS 
 The mean serum albumin levels in patients with chronic periodontitis (3.956 
± 0.049 mg/dL) were significantly less than that in periodontally healthy subjects 
(4.73 ± 0.052mg/dL). Three months after periodontal treatment, the serum albumin 
level increased significantly (4.567 ± 0.017 mg/dL) and approached the levels in 
periodontally healthy subjects (P < 0.05). 
 
CONCLUSION 
 The decrease and increase in serum albumin levels with periodontal disease 
and periodontal treatment respectively indicated an inverse relationship between 
serum albumin levels and chronic periodontitis. 
 
Keywords: Albumin, chronic periodontitis, inflammation, scaling, root planing 
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                                                   INTRODUCTION 
Periodontitis is a destructive chronic infection of the gingiva, periodontal 
ligament and bone that supports the teeth.
1
 The primary clinical features of 
periodontitis include gingival inflammation, periodontal pocketing, clinical 
attachment loss and alveolar bone loss. Chronic periodontitis is considered to start as 
plaque induced gingivitis, a reversible condition that is left untreated may develop 
into chronic periodontitis. Chronic periodontitis distinguished by loss of attachment 
and bone is regarded as irreversible. 
             Periodontitis results in the formation of many inflammatory mediators like                 
C -reactive proteins. Also this will stimulate antibody formation like IgG. A 
significant association between serum albumin concentration and IgG has been 
reported
 2
.C -reactive protein may be used to identify the presence of inflammation in 
individuals with a lower serum albumin concentration. 
3
 
          Serum albumin is a negative acute phase protein and serum albumin might be 
the practical marker of general health status (Phillips et al).
4 
Chronic inflammatory 
conditions such as liver diseases and renal diseases reduces the serum albumin levels. 
(Herrmann et al).
5
 Serum albumin levels remain virtually unchanged even in the 
presence of protein calorie malnutrition in otherwise healthy individuals until 
terminal starvation. Hence, serum albumin concentration should be a criterion, which 
indicates general health. 
           Recently report says that the number of untreated teeth was a significant factor 
associated with serum albumin concentration in elderly. Therefore, it is suggestive 
that oral disease burden might be monitored by the levels of serum albumin.
6
             
Inflammation and malnutrition both reduce the serum albumin concentration by 
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decreasing its rate of synthesis. This suggests that the periodontal disease severity 
might be indicated and monitored by the levels of serum albumin. Therefore, serum 
albumin can be used as a risk predictor for periodontal disease.  
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                                                AIM 
 The aim of this study is to determine whether there is an alteration in the level 
of serum albumin in patients with chronic periodontitis before and after phase I 
therapy. 
 
                                       OBJECTIVES 
 To measure serum albumin levels in control group and in study group at  
T0: Before phase I therapy, 
 T1: After 3 months of Phase I therapy. 
 To correlate the clinical parameters in the control, with study group before 
and after phase I therapy along with serum albumin levels. 
 To compare serum albumin levels in individuals with healthy periodontium 
(control group) and chronic periodontitis (study group). 
  Estimation of serum albumin levels before and after phase I therapy in 
patients with chronic periodontitis. 
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                                    REVIEW OF LITERATURE 
            Periodontitis is a chronic inflammatory condition with a polymicrobial 
infectious in nature, which destroys the tooth-supporting tissues and results in 
attachment and bone loss. After accumulation of bacterial biofilm on the external 
tooth surfaces, periodontitis is induced as an inflammatory‒immune process and 
results in the production of proinflammatory cytokines, local and systemic 
inflammatory responses, and formation of periodontal pockets.
7 
 
           The diagnosis of periodontitis relies on clinical measurements, including 
pocket depth, clinical attachment level, and radiographic findings. However, such 
measurements have limited efficacy in periodontal diagnosis in many cases because 
these parameters mainly indicate previous periodontal disease rather than the current 
disease activity
8
.It is necessary to develop new diagnostic tests so that it would be 
possible to diagnose active disease, predict future disease activity and evaluate 
response to periodontal treatment after clinical recovery of patients from 
periodontitis. Advances in diagnosis of periodontal diseases include moving toward 
diagnostic techniques that can evaluate periodontal disease risk by measuring 
biomarkers. Biomarkers are produced by both healthy individuals and those with 
specific systemic conditions. They are the molecules that is used to monitor the health 
status, disease initiation and response to treatment.
9 
  Acute phase proteins are some of these biomarkers. The acute phase reaction 
consists of a group of metabolic and systemic changes that are induced by an 
inflammatory stimulus. The most critical components of this reaction are acute phase 
proteins that consist of a heterogeneous group of serum proteins synthesized by the 
liver.
10
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           A change in the concentration of acute phase proteins, as a patho-physiologic 
phenomenon, occurs subsequent to a wide range of disorders, including 
inflammation, trauma, infection and infarction. Despite their name, such proteins are 
expressed due to both acute and chronic inflammation.
11 
Acute phase proteins are categorized into two groups: 
1. Positive acute phase proteins such as C-reactive protein, serum amyloid-A, 
pentraxin-3, ceruloplasmin and ferritin, whose serum levels increase during the 
inflammatory response. 
2. Negative acute phase proteins are proteins such as albumin and transferrin, whose 
serum levels decrease with an increase in inflammation severity.
12 
 
SERUM ALBUMIN 
 
                Serum albumin is the most abundant protein in human blood plasma, it 
constitutes about half of serum protein .It is produced in the liver. It is soluble and 
monomeric. Albumin transports hormones, fatty acids and other compounds, buffers, 
and maintain oncotic pressure, among other functions. 
               Albumin is synthesized in liver as preproalbumin, which has an N- terminal 
peptide that is removed before the nascent protein is released from the rough 
endoplasmic reticulum. The product, proalbumin, is in turn cleaved in golgi vesicles 
to produce the secreted albumin. 
SERUM ALBUMIN LEVELS 
            The reference range for albumin concentration in serum is approximately 35-
50g/L (3.5-5.0g/dl)
13
.It has a serum half-life of approximately 20 days.It has a 
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molecular mass of 66.5 KDa. For children less than 3years of age, the normal range is 
broader, 2.9 – 5.5 g/dl. 
           Low albumin (hypoalbuminemia) may be caused by liver disease, nephrotic 
syndrome, burns and protein losing enteropathy, malabsorption, malnutrition
14
, late 
pregnancy, genetic variation and malignancy. 
           High albumin (hyperalbuminemia) is almost always caused by dehydration.
15
 
In some cases of retinol (vitamin A) deficiency, the albumin levels can be high values 
.This is because retinol causes cells to swell with water .This swelling also likely 
occurs during treatment with 13-cis retinoic acid .In lab experiments it has been shorn 
that all- trans retinoic acid down regulates human albumin production. 
Hyperalbuminemia has also been associated with high protein diets.
16
 
FUNCTIONS 
o Maintains oncotic pressure 
o Transports thyroid hormones 
o Transport other hormones in particular ones that are fat – soluble 
o Transports fatty acids ( “ free “ fatty acids) to the liver and to 
monocytes for utilization of energy 
o Transports unconjugated bilirubin 
o Transports many drugs ; serum albumin can affect the half – life of 
drugs  
o Competitively binds calcium ions 
o Serum albumin, which is a negative acute- phase protein , that is down 
– regulated in inflammatory states. As such, it is not a valid marker of 
nutritional status; rather it is a marker of inflammatory state.  
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o Prevents photo degradation of folic acid 
MEASUREMENT 
Serum albumin is commonly measured by recording the change in absorbance 
upon binding to a dye such as bromocresol green or bromocresol purple.
17
 
PROPERTIES 
Albumin is a globular, water soluble unglycosylated serum protein of 
approximate molecular weight of 65,000Daltons. Albumin is negatively charged. The 
glomerular basement membrane is also negatively charged in the body, some studies 
suggest that this prevents filtration albumin in urine. According to this theory, the 
negative charge plays a major role in the selective exclusion of albumin from the 
glomerular filtrate. A defect in this property results in nephrotic syndrome leading to 
loss of albumin in urine. Nephrotic syndrome patients are sometimes given albumin 
to replace lost albumin. 
STRUCTURE 
The general structure of albumin is characterized by several long alpha helices 
allowing it to maintain a relatively static shape, which is essential for regulating 
blood pressure. 
Serum albumin consists of eleven distinct binding domains for hydrophobic 
compounds. One hemin and six long –chain fatty acids which can bind to serum 
albumin at the same time.
18
 
 
 
                                                                                                Review Of Literature 
 
8 
 
TYPES 
Human serum albumin 
Bovine serum albumin (often used in medical molecular biology labs) 
THERAPEUTIC USES 
            Human albumin solution is available for medical use, usually at concentration 
of 5-25% .Human albumin often used to replace blood volume in trauma, burns and 
surgery patients. 
           Human serum albumin is used as a component of a frailty index.
19
 
            It has been shown to give better results than other fluids when used to replace 
volume, but is frequently used in conditions where loss of albumin is a major 
problem, such as liver disease with ascites. 
             Human serum albumins have been used to potentially reverse drug / chemical 
toxicity by binding to free drug / agent. 
GLYCATION 
         Human blood protein like haemoglobin
20
 and serum albumin
21
 may undergo a 
slow non – enzymatic glycation, mainly by formation of Schiff base between amino 
groups of lysine residues and glucose molecules in blood. This reaction is inhibited in 
the presence of antioxidant agents.
22
 Elevated glycoalbumin is absorbed in diabetes 
mellitus.
23
 
         Glycation has potential to alter the biological structure and function of serum 
albumin protein.
24
 Moreover, the glycation can result in formation of Advanced 
Glycation End Products, which leads to tissue damage via alteration of the structures 
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and function of tissue proteins and generation of reactive oxygen intermediates. They 
also interfere with the normal product of nitric oxide in cell.
25
 
OXIDATION 
        The albumin is the predominant protein in most body fluids, its Cys34 represents 
the largest fraction of free thiol exists in both reduced and oxidized forms
26
. In 
plasma of healthy young adults , 70-80% of total  HSA contains the free sulfhydryl 
group of Cys34 in reduced form or mercaptoalbumin
27
 .However in pathological 
states characterized by oxidative stress and during aging process ,the oxidized form  
could predominate
28
.The albumin thiol reacts with radical hydroxyl, hydrogen 
peroxide and reactive oxygen species as peroxynitrite and have been shown to 
oxidize Cys34 to sulfenic acid derivative ,it can be recycled to mercaptoalbumin 
,however at high concentration of reactive species leads to irreversible oxidation to 
sulfonic acid affecting it structure
29
.Presence of  reactive oxygen species , can induce 
irreversible structural damage and alter protein activities. 
LOSS VIA KIDNEY  
        In healthy kidney, albumin size and negative electric charge exclude it from 
excretion in the glomerulus. This is not always the case, as in some diseases including 
diabetic nephropathy, which can sometimes be a complication of uncontrolled or of 
longer term diabetes in which protein can cross the glomerulus. The lost albumin can 
be detected by a simple urine test. Depending on the amount of albumin loss, a 
patient may have normal renal function, microalbuminuria or albuminuria. 
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SERUM ALBUMIN IN RELATION TO PERIODONTITIS  
  Hermann et al. (1992) detected that many conditions, such as inflammatory 
states, liver diseases, and renal diseases, have been indicated to reduce serum albumin 
levels.
30
 Serum albumin is the main protein synthesized by the liver. In elderly 
individuals it seems to be imperative that the impaired dentition status and a lean life 
style along with the possibility of compromised systemic health status would reflect 
within the values of serum albumin concentration.
31
  
  Serum albumin is a negative acute phase protein supports the contention that 
serum albumin is a marker of inflammation.
32
 Chronic diseases are associated with 
inflammation and the release of inflammatory cytokines such as interleukin‑1, 
interleukin‑6, and tumor necrosis factor‑α, which cause a decrease in serum albumin 
(Schalk et al. 2004).
33
 Moreover, malnutrition may also be monitored by means of 
serum albumin concentration (Don and Kaysen 2004).
 
Therefore, albumin 
concentration is associated with nutrition and inflammation (Kaysen et al. 2002). 
  There has also been a linkage of serum albumin level and mortality rate. 
Investigations by Corti et al.
34
 have reported graded increase in mortality rate with 
decreasing serum albumin levels. However, it seems more evident that serum 
albumin levels below 4 g/dL have higher mortality rate.  
            Shibata et al. reported significantly different 10‑year survival rate with a 
quartile of serum albumin levels. Therefore, the periodontal disease status has a 
substantial influence not only on the subject’s serum albumin levels but also on 
general health aspects.
35
                                  
           Iwasaki et al evaluated albumin, a negative acute phase protein, in patients 
with periodontitis and concluded that there might be an inverse relationship between 
periodontitis and albumin serum levels.
36
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  Kshirsagar et al 
37
 studied levels of serum albumin and CRP among patients 
on HD. In this study, patients with severe periodontitis had low serum albumin levels 
(odds ratio 8.20; 95% confidence interval 1.61-41.82; p = 0.01) compared with 
individuals without severe periodontitis disease after adjustment for several factors. 
There was no association of CRP levels and severity of the disease. 
  Shirmohamadi et al 2016 
38
The mean transferrin serum level in patients with 
chronic periodontitis (213.1 ± 9.2 mg/dL) was significantly less than that in 
periodontally healthy subjects (307.8 ± 11.7 mg/dL). After three months periodontal 
treatment, the transferrin serum level increased significantly (298.3 ± 7.6 mg/dL) and 
approached the levels in periodontally healthy subjects (P < 0.05). 
           There is decrease in transferrin serum levels with periodontal disease and 
increased after periodontal treatment, respectively, indicated an inverse relationship 
between transferrin serum levels and chronic periodontitis. 
           Sawant et al
39
 done a study to evaluate the role of serum albumin and liver 
enzymes in the cause effect relationship of chronic periodontitis .And found that there 
is Significant reduction in serum albumin levels in chronic periodontitis patients. And 
concluded there was significant inverse association between serum albumin and 
clinical attachment loss in patients with chronic periodontitis, also found that there 
was significant increase in serum ALT and ALP levels in chronic periodontitis 
patients as compared to healthy subjects. Such a study will help the clinician for 
dental referral of the patient with high ALT and ALP levels. 
              Navkiran Kaur
40
 conducted the study to evaluate the relationship between 
periodontal health status and serum albumin levels. The findings of this clinical trial 
suggest an inverse relationship between the serum albumin concentration and chronic 
periodontal disease.  
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            In a study by Bhuvan et al
41
 it was found that Periodontal condition is related 
to the control of glucose level among patients with type 2 diabetes and periodontal 
disease. Periodontal treatment can effectively reduce the level of glucose and 
Glycated albumin as well as it improves the periodontal condition in type-2 diabetes 
patients with periodontal disease. 
 In a study by Veisa et al
42
 on Albumin as a Prognostic Factor for 
Malnutrition and Inflammation in Chronic Kidney Disease, with main goal to 
evaluate, for the first time, the correlation between albumin level, periodontal disease 
and inflammation in a cohort of haemodialysis patients. It was found that in HD 
patients, albumin and nutritional status (evaluated by SGA score) were associated 
with a significantly increased death risk. Further evidence is needed in order to 
support inflammation markers as a long term predictor for decline in ESRD patients. 
 In a study by Pimpale S et al to correlate between periodontal disease and 
serum albumin concentration in chronic periodontitis patients and suggested that 
serum albumin concentration is an important risk indicator in chronic periodontitis 
patients.  
NON-SURGICAL THERAPY: 
 The main goal of the treatment of patients with periodontitis is to establish 
proper infection control, i.e, to reduce the bacterial load below the individual 
threshold level for disease. Cause-related periodontal therapy is usually the initial 
phase of periodontal treatment. The aims are to eliminate supra- and sub-gingival 
bacterial deposits and to prevent their recurrence (Haffajee et al. 1997)
.43
 even in the 
most severe cases of periodontal disease, cause-related periodontal therapy most 
often precedes surgical therapy. This is done so that the periodontal infection is 
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reduced and the overall tissue quality is improved prior to surgery. This procedure 
may also limit the areas requiring surgery. 
The aims can be achieved by the following procedures/measures: 
- Motivate the patient to understand periodontal disease and the importance of 
co-operation in order to combat the disease. Optimal treatment results and 
stable long term conditions depend on optimal self-performed oral hygiene 
and compliance towards regular maintenance visits. 
- Provide the patient with custom-made oral hygiene instruction and reassess 
the results from time to time and reinforce the technique, if necessary. 
Maintaining optimal personal hygiene is paramount because at least one study 
showed that instrumentation alone without improving patient’s plaque control 
may lead to microbial repopulation of the instrumented sites shortly after 
scaling and root planing (Magnusson et al. 1984)
44
 
Non-surgical periodontal therapy include scaling and root planing to remove 
bacterial plaque and calculus subgingivally by mechanical means, using either 
manual instruments such as hand scalers/curettes or machine-driven instruments such 
as sonic or ultrasonic scalers.  Badersten et al (1981)
45
, Torfason et al (1979)
46 
have 
shown that both instrumentation approaches could achieve similar results, but 
according to Leon & Vogel (1987)
47 
ultrasonic instruments might be more suitable in 
furcation areas.  
Although the word “planing” means to remove substance for achieving a smooth 
surface, Nyman et al (1988)
48
 showed that it was not necessary to plane the root 
surfaces until smooth or to remove the so called “diseased/ contaminated” cementum.  
A clinical study by Oberholzer & Rateitschak 1996
 
concluded that the 
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establishment of a smooth and hard root surface was not a critical factor in 
periodontal therapy. 
Non-surgical treatment improves clinical parameters including bleeding on 
probing, probing depths and probing attachment levels, provided that patients can 
obtain and maintain a proper plaque control. 
Singletary et al 1982
49
, Greenewell et al 1984 
50
, Lavanchy et al 1987
51
 
reported a significant reduction in gingival inflammation 1-3 months after phase I 
therapy. Hughes & Caffesse 1978
52
 demonstrated that reduction of probing depth 
following mechanical instrumentation results from a combination of gain in clinical 
attachment and increase in gingival recession. Proye et al 1982
53
 noted recession 
after one week and a gain of clinical attachment by 3 weeks after phase I therapy. 
After a single episode of scaling and root planing, pockets were reduced to 1.36 mm. 
This consisted of 0.84 mm recession and 0.52 mm attachment gain. 
Morrison et al 1982
54
 in another examination of data from the previously 
mentioned 8-year longitudinal study analyzed the effect of gingivitis scores on 
probing depth and attachment levels. For pockets 1 to 3 mm and 4 to 6 mm there was 
no difference in pocket reduction maintenance. For attachment there was no 
significant difference in 1 to 3 mm probing depths and in 4 to 6 mm pockets, lower 
gingivitis scores had better gain the first 2 years but thereafter no difference was 
recorded. For 7 to 12 mm pockets, the lower gingivitis scores seemed to result in 
better probing levels and attachment gain for the first 3 years but this was not 
maintained throughout the experiment. And the severity of gingivitis did not affect 
the maintenance of pocket depth reduction or clinical attachment levels. 
Ramfjord et al 1982
55
 reported that deepest sites demonstrated the greatest 
pocket reduction after instrumentation. They conducted a study in pockets with 1-
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3mm, 4-6mm and ≥7mm for 5years and found the greatest pocket reduction in group 
with ≥7mm pocket depth. But they also found a greater amount of recession in this 
group. 
Cobb 1996
56 
reported that for shallow pockets with initial probing depth 1-
3mm, the mean reduction of probing pocket depth (PPD) was 0.03mm and loss of 
probing attachment level (PAL) was 0.3mm. For moderate pockets with initial PPD 
of 4-6mm, the mean reduction of PPD was about 1.29mm and the PAL gain was 
0.55m . For deep pockets with initial PPD ≥ 7mm, the mean reduction of PPD was 
about 2.16mm and the PAL gain was 1.19mm. 
The number of sites that bleed on probing also markedly reduces following 
nonsurgical therapy. Cobb (2002)
57 
reviewed many studies and found that the mean 
reduction in bleeding on probing from baseline levels was about 45%.  
Non-surgical periodontal therapy has been proved to be effective in 
controlling the disease in most patients (Badersten et al. 1984, Claffey & Egelberg 
1995)
58,59 
Furthermore, most of the stabilized periodontal conditions can be 
maintained throughout time if the patients are committed to have supportive 
periodontal care (Axelsson & Lindhe 1981, Renvert & Persson 2004).
60,61
 
Philstrom et al. (1981)
62
 in a 4-year study utilizing multi-rooted teeth, 
compared scaling and root planing to modified Widman surgery. Seventeen patients 
received thorough scaling and root planing as well as oral hygiene instructions. A 
modified Widman flap was then performed on one half of each subject's dentition. 
Patients were recalled 3 to 4 times a year for 4 years. The data were separated into 3 
groups by initial pocket depth; 1 to 3 mm, 4 to 6 mm, and > 7 mm. Both methods 
resulted in increased probing depth and loss of attachment in the 1 to 3 mm group, in 
the 4 to 6 mm group both procedures resulted in reduction in probing depth and 
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maintenance of attachment levels with the root planing resulting in slightly more gain 
in attachment. The > 7 mm group showed the greatest reduction in probing depth and 
gain in attachment with better results in the flap procedures. The results indicate that 
both procedures were effective in treating moderate to advanced periodontitis. The 
additional flap procedure tended to result in greater probing reduction and attachment 
gain for deeper pockets.  
Philstrom et al. (1983)
63 
in a second report analyzed the 6.5 year results of 
the previous study. This report concludes that scaling and root planing alone or in 
combination with modified Widman flap surgery resulted in sustained decreases in 
gingivitis, plaque, and calculus and neither procedure appears to be superior with 
respect to these parameters. Seventeen patients diagnosed with moderate-advanced 
periodontitis were utilized in a split-mouth design study to compare the effects of 
scaling and root planing alone and combined with modified Widman flap surgery. 
Data were collected at baseline, 6 months following active therapy and every year up 
to 4 years, then at 5 1/2 and 6 1/2 years. Probing depth did not change for 1 to 3 mm 
pockets treated by either scaling or root planning alone or in combination with 
modified Widman flap surgery. For pockets 4 to 6 mm, both treatment procedures 
resulted in equally effective sustained pocket reduction. Deep pockets (> 7 mm) were 
initially reduced more by the flap procedure. After 2 years, no consistent difference 
between treatment methods was found in degree of pocket reduction. For pockets 
initially 4 to 6 mm in depth, attachment level was sustained by both procedures. 
Pockets > 7 mm in depth treated by either procedure resulted in a sustained gain in 
attachment. 
 Philstrom et al. (1984)
64 
in a third report examined the response of molar and 
non-molar teeth to scaling and root planing alone or scaling and root planing plus a 
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flap procedure. At 6 1/2 years, non-molar teeth had an average of about 1.0 mm less 
probing depth than molar teeth irrespective of type of procedure performed. There 
was greater probing depth and more apical attachment level on molar than on non-
molar teeth treated by either method for 4 to 6 mm pockets. In > 7 mm pockets, the 
flap resulted in less pocket depth on non-molars than molars, but no difference in the 
attachment level for either method. Nineteen of the 453 teeth included in the study 
were extracted throughout the study; 11 of these were extracted after therapy. 
 Hill et al. (1981)
65
 published a 2-year study of scaling and root planing 
compared to modified Widman surgery. This 90-patient study included multi-rooted 
teeth. Following a hygienic phase which included scaling and root planing and oral 
hygiene instructions;, each quadrant was treated by 1 of 4 treatments (pocket 
elimination, modified Widman flap (MWF), subgingival curettage, and scaling and 
root planing). Measurements which included pocket depth and attachment levels were 
taken at the initial exam, after the hygienic phase and 1 and 2 years after treatment. In 
the 1 to 3 mm crevices there was a slight loss of attachment after all types of 
treatments. In the 4 to 6 mm pockets there was a significant reduction in probing 
depth after all modalities with the greatest reductions after pocket elimination and 
modified Widman flap, and a loss of attachment for pocket elimination and a gain for 
curettage and scaling. In the > 7 mm pockets there was a significant reduction after 
all modalities with the greatest reduction after pocket elimination, and no significant 
differences in attachment results among the 4 methods. None of the surgical 
modalities had any better effect than scaling and root planing alone in maintenance of 
periodontal support which was not directly related to reduction in pocket depth. 
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Cercek et al. (1983)
66 
reported results of a 2-year study that compared 
supragingival plaque control to subgingival plaque control to scaling and root 
planing. Seven patients with chronic periodontitis were observed during 3 phases of 
treatment: 1) tooth brushing and flossing; 2) Perio-Aid used subgingivally; and 3) 
subgingival debridement. Plaque scores ranged from 38 to 99% with a mean of 74% 
at the initial exam. These scores were reduced to 5 to 15% and were maintained 
throughout the study. The mean bleeding score of 71.7% was reduced to 40.9% in 
Phase I, no change in Phase II, and reduced to 23% in Phase III. Deeper sites showed 
more bleeding than shallower sites throughout the study. The mean probing depth of 
4.4 mm was reduced to 4.0 mm in Phase I, no improvement in Phase II, and reduced 
to 3.2 mm after instrumentation. Probing attachment level showed a mild loss through 
Phase II, but improved attachment levels were found after instrumentation. An 
increasing gingival recession was noted during the study. Less effect was derived 
from patient-performed plaque control, whether supra- or subgingival. The bulk of 
the effect was derived from professional subgingival instrumentation (SRP). 
 Badersten et al 1981
45 
in a 13-month study of patients with moderate 
periodontitis compared the effect of hand versus ultrasonic instrumentation on 
attachment levels of single-rooted teeth. Incisors, canines, and premolars in 15 
patients with moderately advanced periodontitis were treated by hand and ultrasonic 
non-surgical therapy. Improvements in plaque scores, bleeding on probing, decreased 
probing and attachment levels were similar for both treatment methods. It was shown 
that shallower sites had a slight loss of attachment while deeper sites showed some 
improvement. 
Badersten et al. 1984A
58
 reported 24-month results of a study comparing 
hand to ultrasonic instrumentation in patients with severe periodontitis. Sixteen 
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patients with severely advanced periodontal disease were treated by hand or 
ultrasonic non-surgical therapy. Comparable results were obtained by both methods. 
It has been shown that the deep probing depths could be successfully treated non-
surgically based on probing depth, probing attachment levels, bleeding on probing, 
plaque, and gingival recession. It was shown that shallower sites were at risk of 
losing attachment, while the deep sites were more likely to gain attachment. Deeper 
residual probing sites were more likely to bleed on probing. 
Badersten et al. 1984B
67
 compared the effect of a single session of scaling 
and root planing to repeated sessions of scaling and root planing. Incisors, canines, 
and premolars were studied in 13 patients with severe periodontitis. Teeth were 
instrumented using ultrasonic instruments, and repeated instrumentation in one side 
of the jaw was performed after 3 and 6 months. A gradual and marked improvement 
took place during the first 9 months. There is no differences in results could be 
observed when comparing the effects of a single versus repeated instrumentation. 
Deep periodontal pockets in incisors, canines, and premolars may be treated by 
plaque control and one episode of instrumentation. 
Badersten et al (1985A)
 68
 reported a study of the effect of operator 
variability on the results of the scaling and root planing procedure. Twenty patients 
whose dentition displayed generalized severe periodontal destruction were selected 
for the study. The incisors, canines, and premolars in either the maxilla or the 
mandible were studied. The periodontal pockets were debrided using either hand 
and/or ultrasonic instruments under local anesthesia by a periodontist or by 1 of 5 
dental hygienists. A split mouth design was used with measurements of dental plaque, 
bleeding on probing, probing depth, and probing AL recorded at the initial exam and 
at every third month by an examiner not involved with treatment. The results indicate 
                                                                                                Review Of Literature 
 
20 
 
that deep periodontal pockets in incisors, canines, and premolars may be successfully 
treated by plaque control and one episode of instrumentation and that operator 
variability between highly skilled clinicians is minimal. 
Badersten et al. (1985B)
 69 
examined patterns of probing attachment loss 
following scaling and root planing. Incisors, canines, and premolars in 33 patients 
with generalized periodontal destruction were studied for patterns of probing 
attachment loss. Patients received supra- and subgingival debridement after oral 
hygiene instructions, and were followed for 24 months. Measurements were made 
every third month and 7 patterns of probing attachment were identified. Seventy-three 
percent (73%) of sites showed a gradual change. Seventeen percent (17) showed an 
early loss followed by a stabilization of attachment levels. Shallower sites showed a 
pattern of early loss followed by stabilization while deeper sites showed a gradual 
loss. 
In general, clinicians should assess healing four to six weeks after performing 
root planning (AAP 1989)
70
. Cercek and coworkers (1983) noted clinical 
improvements continued for 8 months however, most of the healing occurred during 
the first month.  
Similarly, Kaldahl and colleagues (1988) demonstrated that the repair 
process extended for 1 year. It appears that the greatest changes with respect to 
probing depth reduction and gain of clinical attachment can be recorded after 4 to 6 
weeks, but gradual repair and maturation of the periodontium may occur over 9 to 12 
months. 
Longitudinal studies by Ramfjord et al (1982)
55 
 indicated that scaling and 
root planing arrested attachment loss as well as surgical therapy regardless of probing 
depths. However, information relating to length of therapy, skill level of therapists, 
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compliance of patients with recall intervals and plaque control, responsibilities of 
clinicians for long-term maintenance and disease activity status need further 
clarification. Concerns regarding these issues must be integrated into therapeutic 
decisions, because they can dramatically affect interpretation and application of 
reported data. 
        In a study by Kaur H et al
71
 it was shown that lower number of erythrocytes 
(RBS’s) and haemoglobin in periodontitis patients compared to healthy individuals, 
and no remarkable differences in levels of MCH, MCHC, and MCV were found 
between Test group and Control group. Thus, based on these results, it can be 
concluded that, like any other chronic condition, chronic periodontitis can be a 
causative factor for anaemia proving its influence systemically. 
.     Abdul S Aziz et al
72
 evaluated the effect of non-surgical therapy on some 
oxidative stress markers in patients with chronic periodontitis and found that chronic 
periodontitis patients show higher inflammatory manifestations and oxidative stress. 
SRP helps in lowering inflammatory burden and hence, it may be a useful support in 
the control and prevention of various inflammatory diseases associated with chronic 
periodontitis. 
In a study by Sawant et al significant reduction in serum albumin levels in 
chronic periodontitis patients were seen. There was significant inverse association 
between serum albumin and clinical attachment loss in patients with chronic 
periodontitis. 
           Based on the observations above, we hypothesized that a decrease in serum 
albumin levels might be related to chronic periodontitis and a return to its normal 
levels can be expected in response to periodontal treatment. 
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Therefore, the present study was undertaken to: 
  To measure serum albumin levels for control group and for study group at  
T0: Before phase I therapy, 
 T1: After 3 months of Phase I therapy. 
 To correlate the clinical parameters in the control, with study group before 
and after phase I therapy along with serum albumin levels. 
 To compare serum albumin levels in individuals with healthy periodontium 
(control group) and chronic periodontitis (study group). 
  Estimation of serum albumin levels before and after phase I therapy in 
patients with chronic periodontitis. 
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                                 MATERIALS AND METHODS 
SOURCE         
The study population was selected from the outpatient section of the 
Department of Periodontics, Tamil Nadu Government Dental College and Hospital, 
Chennai.   
STUDY DESIGN 
The study is of a case control type. The study participants will be recruited 
prospectively in this study.   
SAMPLE SIZE 
A total of 30 patients need to be selected for study. 
              Group I- 15 subjects with healthy periodontium. (control group) 
              Group II- 15 subjects with chronic periodontitis (study group) 
 Levels of serum albumin will be compared between patient affected with chronic 
periodontitis before and after phase I therapy and healthy individuals. 
ELIGIBILITY CRITERIA 
Inclusion criteria  
 Periodontally healthy individuals - For control group 
 Either sex. 
 Study group: Patient affected with chronic periodontitis showing probing 
pocket depths > 5mm.  
 Age 30 – 50 years. 
 Agreement to participate in study program. 
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Exclusion criteria  
 Smokers. 
 Patients with systemic diseases such as cardiovascular diseases, renal 
diseases, liver diseases and medically compromised patients such as 
uncontrolled diabetes, immunosuppression, bleeding disorders, cancer, 
stroke and sever osteoporosis.  
 Aggressive periodontitis    
 Patient who underwent periodontal treatment in past 6 months.  
 Patient under drugs which affects serum albumin levels. 
 Pregnancy and lactation 
 Patients under bisphosphonates medication 
 Patients under the uses of antibiotics within past 6 months. 
ARMEMENTATIUM 
For clinical examination 
1. Mouth mirror 
2. William’s Probe 
3.  Explorer 
4. Dental tweezers 
5. Cotton rolls 
6. Sterilized disposable gloves 
7. Disposable face masks and head cap 
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For collection of blood sample 
1. Sterile cotton 
2. Surgical spirit 
3. Disposable syringe with 22gauge needle 
       4.  Tourniquet.  
 For Phase I therapy 
1. Mouth mirror 
2. Explorer 
3. Scalers and curettes 
4. Kidney tray 
5. Cotton Rolls 
6. Disposable Gloves 
7. Disposable Facemask 
8. Disposable Head cap 
9. Disposable syringe 24 gauge needle 
10. Local Anaesthetic solution 
12. 0.9 % Normal saline 
            13. Ultrasonic scaling unit manufacturer Wood pecker 
  
 
 
                                                                                              Materials and Methods 
 
26 
 
STUDY DESIGN  
The study was carried out in 30 subjects divided into 2 groups with 15 
subjects in each group: Group I-15 subjects with healthy periodontium (control 
group), Group II -15 subjects with chronic periodontitis (study group) . Ethical 
clearance was obtained from the Institutional Ethical Committee and ethical 
principles were meticulously followed throughout the study. After explaining the 
study protocol, informed consent was obtained from all the selected subjects. A 
thorough medical and dental history of the subjects was taken. All the subjects 
underwent full-mouth periodontal probing and charting and clinical and laboratory 
evaluation  
CLINICAL PARAMETERS ASSESSMENT  
The following clinical parameters were evaluated for all the subjects:  
1. Plaque index – Silness and Loe 196473 
2. Gingival bleeding index – Ainamo and Bay 1975 74 
      3. Probing depth in mm (PD) – Carranza 10th ed 75 
      4. Clinical attachment level in mm (CAL) – Carranza 10th ed75 
 
Plaque Index (Silness and Loe 1964)  
All teeth were examined at 4 sites each (disto-facial, facial, mesio-facial, lingual / 
palatal) and were scored as follows:  
Scoring Criteria 
Score 0: No plaque in the gingival area.  
Score 1: A film of plaque adhering to the free gingival margin and adjacent area of 
the tooth. The plaque is recognized only by running a probe across the tooth surface.  
                                                                                              Materials and Methods 
 
27 
 
Score 2: Moderate accumulation of plaque within the gingival pocket and on the 
gingival margin and / or adjacent tooth surface that can be seen by the naked eye.  
Score 3: Abundance of soft deposits within the gingival pocket and / or on the 
gingival margin and adjacent tooth surface.  
CALCULATION 
Plaque index per tooth = Total score/4  
Plaque index per individual ═ Total P I per tooth / Total number of teeth examined  
Interpretation  
Score 0 – Excellent oral hygiene  
0.1 to 0.9 – Good oral hygiene  
1.0 to 1.9 – Fair oral hygiene  
2.0 to 3.0 - Poor oral hygiene
 
Gingival Bleeding Index (Ainamo & Bay 1975)  
Starting distobuccally, the probe was gently inserted into the sulcus and run to 
the buccal and mesial surfaces of every tooth at an angle of about 45º. This was 
repeated for all the teeth present. Similarly probing was carried out at palatal/lingual 
sites. The total number of bleeding sites per tooth was thus recorded for every tooth 
except the third molar.  
Scoring Criteria  
Positive score (1) - Presence of bleeding within 10 seconds  
Negative score (0) - Absence of bleeding 
 % of bleeding sites =  Total number of positive score x 100  
Total number of surfaces of all teeth 
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Probing Pocket Depth (PPD)  
            Probing Pocket Depths were measured from the gingival margin to the base of 
the pocket in millimeters using William’s Periodontal Probe. The probe was walked 
within the gingival sulcus along the circumference of the tooth. Keeping the probe 
parallel to the long axis of the selected tooth, six measurements were made per tooth 
(Mesiobuccal, Distobuccal, Midbuccal, Mesiolingual, Distolingual and Midlingual). 
Clinical Attachment Level (CAL) 
Clinical Attachment Level was measured from the Cemento – Enamel 
Junction (CEJ) to the base of the pocket using William‘s Periodontal Probe.  
When the gingival margin was located on the anatomic crown, the level of the 
attachment was determined by subtracting from the probing depth, the distance from 
the gingival margin to the CEJ. If both were the same, the loss of attachment was 
calculated to be zero.  
When the gingival margin coincided with the CEJ, the loss of attachment was 
calculated as equaling the probing depth. When the gingival margin was located 
apical to the CEJ, the loss of attachment was greater than the probing depth and 
therefore the distance between the CEJ and the gingival margin were added to the 
PD.  
Three measurements were made on the buccal aspect and three on the lingual aspect 
of each tooth – total of six sites per tooth ( Mesiobuccal, Midbuccal, Distobuccal, 
Mesiolingual, Midlingual, and Distolingual). 
 b) Radiographic parameters 
 Intra oral periapical radiographs were  taken to assess the bone loss. 
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 c) Routine blood investigation 
 Haemoglobin 
 Bleeding time 
 Clotting time 
 Total leukocyte count 
 Differential leukocyte count 
 Random sugar 
 d)  Estimation of Serum Albumin Levels  
METHOD OF COLLECTION OF BLOOD SAMPLE 
              Venous blood was drawn from the participants those were selected for the 
study. The subjects were informed, and consent was taken. They were made to 
tighten a fist so that vein was more palpable, and antecubital vein was selected for 
veni puncture. A tourniquet was applied about 1-2 inches above the antecubital fossa. 
After disinfecting the puncture site with 10% isopropanol solution, blood was 
withdrawn using a syringe with 24 gauge needle. Tourniquet was released as the 
blood flow began. After drawing 3 ml of blood, sterile cotton ball was placed on the 
puncture site and needle was withdrawn. The subjects were instructed to apply mild 
finger pressure on the site for few minutes to avoid oozing out of blood. 
PRINCIPLE OF THE ASSAY  
This kit uses Bromocresol green for the Quantitative determination of albumin. 
 The method is based on the specific binding of bromocresol green (BCG), an anionic 
dye, and the protein at acid pH produce a color change of the indicator from yellow –
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green to green –blue with the resulting shift in the absorption wavelength of the 
complex. The intensity of the color formed is proportional to the concentration of 
albumin in the sample.  
          BCG + Albumin  PH  4.3   BCG-albumin complex 
 
 PROCEDURE  
1. Assay conditions :  
Wavelength …………………..630 nm(600-650)  
Cuvette …………………………1 cm light path  
Temperature …………………15-25 oC  
2. Adjust the instrument to zero with distilled water.  
3. Pipette into a cuvette :  
 4. Mix and incubate for 10 minutes at room temperature (15-250C).  
5. Read the absorbance (A) of the samples and standard, against the blank.  
The color is stable for 60 minutes at room temperature 
       Tubes       Blank      Sample       Standard 
     Reagent       1.0ml    1.0ml       1.0ml 
     Sample        -    5µml       - 
     Standard       -          -       5µml 
Calculations: 
(A) Sample ÷ (A) Standard × 5(standard concentration ) = g/dl albumin   
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  PHOTOGRAPH 1: GROUP I-CONTROLGROUP  
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PHOTOGRAPH 2: GROUPII-GENERALISED CHRONIC PERIODONTITIS 
(BASELINE) 
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PHOTOGRAPH 3: GROUP II-GENERALISED CHRONIC PERIODONTITIS 
(3 MONTHS POST OP)  
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PHOTOGRAPH 4: ARMAMENTARIUM FOR CLINICAL EXAMINATION 
AND SAMPLE COLLECTION 
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  PHOTOGRAPH 5 : COLLECTION OF THE VENOUS BLOOD SAMPLE 
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PHOTOGRAPH – 6 ARMAMENTARIUM FOR PHASE I THERAPY 
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PHOTOGRAPH – 7 : CENTRIFUGAL MACHINE 
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PHOTOGRAPH – 8  ALBUMIN KIT 
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PHOTOGRAPH -9: BIOCHEMICAL ANALYZERS 
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                                STATISTICAL ANALYSIS  
          The statistical analysis was done using the computer software program SPSS 
version 20 (Statistical Package for Social Science, Version 20). Data was expressed 
as mean ± standard deviation of the parameters evaluated. In Group I, the clinical and 
laboratory parameters were evaluated at baseline and   in Group II at baseline and 3 
months post operatively.  
STATISTICAL TESTS USED:  
1.      Tests of normality:  Shapiro wilk’s test. 
      2.      To compare the parametric values between baseline and 3 months in both 
groups Paired sample t test was performed. 
       3.    To compare the parametric values between two groups Independent sample 
t test was performed. 
       4.     To determine the correlation serum albumin with clinical parameters 
Pearson rank correlation coefficient was performed. 
P value of <0.05 is considered significant in the present study. 
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                                                  RESULTS 
  
                 In the present interventional study, 30 subjects were included, among them 
were Group I- 15 subjects with healthy periodontium. (Control group)  Group II- 15 
subjects with Generalised Chronic periodontitis (study group). The parameters 
assessed were plaque index, gingival bleeding index, probing depth and clinical 
attachment level (clinical) and serum albumin level (laboratory) in Group I and at 
baseline and 3 months post-operatively in Group II patients. 
INTRAGROUP COMPARISON 
1. PLAQUE INDEX  
Group I: The mean plaque index score in group I  at baseline was 0.644±0.033 
Group II : The mean plaque index score  in group II at baseline was 2.476± 0.065 
and at 3 months was 0.984 ±0.98 .Mean difference in plaque index score in group II  
between baseline and 3 months post-operative value was 1.492±0.118 which was 
found to be statistically significant (p= 0.000) 
INTERGROUP COMPARISION 
          Mean difference between the baseline values of PI between Group I and Group 
II 1.832± 0.074 which was found to be statistically significant. (p= 0.000)  
2. PROBING POCKET DEPTH  
Group I: The mean probing pocket depth score in group I  at baseline was 
2.15±0.041 
     Group II:  The mean PPD index in group II at base line was 5.174 ±0.292 and at 
3 months was 3.306 ±0.210. 
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  Mean difference in plaque index score in group II  between baseline and 3 
months post-operative value was 1.868 ±0.159 which was found to be statistically 
significant (p= 0.000) 
 INTERGROUP COMPARISON 
          Mean difference between the baseline values of PPD between Group I and 
Group II 0.340± 0.104which was found to be statistically significant. (p= 0.001)  
3. CLINICAL ATTACHMENT LEVEL  
Mean CAL index in group II at base line was 5.024 ±0.319 and at 3 months was 
3.454 ±0.223. Mean difference in plaque index score in group II between baseline 
and 3 months post-operative value was 1.570±0.297 which was found to be 
statistically significant  
(p= 0.000)  
4. GINGIVAL BLEEDING INDEX  
Mean GB index in group II at base line was 74.820 ± 3.022 and at 3 months was  
15.113 ±1.487. Mean difference in plaque index score in group II  between baseline 
and 3 months post-operative value was 59.706±2.910  which was found to be 
statistically significant (p= 0.000)  
5. SERUM ALBMIN LEVEL 
INTRA GROUP COMPARISON 
Group I:     The mean serum albumin level in group I at baseline was 4.73±0.052. 
Group II:    Mean serum albumin level in group II at base line was 3.956 ± 0.049 and 
at 3 months was 4.567 ±0.017. Mean difference in serum albumin level in group II 
between baseline and 3 months post-operative value was 0.611± 0.045 which was 
found to be statistically significant. (p= 0.000)  
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 INTER GROUP COMPARISON: 
          Mean difference of serum albumin levels between group I and Group II at 
baseline was 0.777 ± 0.072 which was found to be statistically significant. (p=0.000) 
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TABLE 1 : MASTER CHART – GROUP 1 ( CLINICAL PARAMETERS) 
CONTROL  GROUP 
S. NO AGE SEX BASELINE  PI 
BASELINE 
PPD 
BASELINE 
CAL 
BASELINE 
GBI 
1.        25 F 0.65 2.27 0 0 
2.        30 M 0.45 2.41 0 0 
3.        29 F 0.85 2.02 0 0 
4.        28 M 0.83 1.98 0 0 
5.        35 M 0.56 2.02 0 0 
6.        28 F 0.5 2 0 0 
7.        29 M 0.56 2.34 0 0 
8.        28 F 0.64 2.13 0 0 
9.        30 F 0.5 2.16 0 0 
10.    25 F 0.56 2.13 0 0 
11 30 F 0.81 2.1 0 0 
12 29 M 0.78 2.2 0 0 
13 32 F 0.55 2.31 0 0 
14 30 M 0.7 1.9 0 0 
15 25 F 0.72 2.4 0 0 
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TABLE 2: MASTER CHART – GROUP II (CLINICAL PARAMETERS ) 
CHRONIC PERIODONTITIS 
  
S. 
NO 
  
  
AG
E 
  
  
SEX 
  
  
BASE
LINE 
PI 
  
BASE 
LINE 
PPD 
  
BASE 
LINE 
CAL 
  
BASE 
LINE 
GBI 
  
3MONTH 
PI 
  
3MONTH 
PPD 
  
3MONTH
CAL 
  
3MONT
H 
GBI 
1.   
     40 F 2.38 5.81 5.1 83.7 0.87 3.32 3.65 13.4 
.      
  45 F 2.13 4.18 4.07 68.4 0.62 2.14 2.56 10.5 
3.   
     43 F 2.76 6.26 6.18 79.4 0.98 4.21 4.33 22.6
4.   
     45 F 2.67 6.12 6.14 80.5 0.42 4.02 4.22 17.6 
5.   
     45 M 2.56 7.12 6.98 91.3 1.05 5.02 5.22 24.6 
6.   
     38 F 2.45 6.38 6.24 67.5 0.76 4.02 4.12 11.2 
7.   
     40 M 2.78 6.28 6.24 87.6 0.76 3.98 3.5 24.4 
8.   
     32 M 1.98 5.13 5.08 55.6 0.32 3.03 3.13 9.5 
9.   
     42 M 2.8 5.5 5.25 89.5 1.05 3.28 3.22 10.5 
10.
    42 M 2.34 4.6 4.4 75.4 1.32 2.3 2.33 8.6 
11.
    34 M 2.7 3.8 4.55 51.2 1.1 2.2 2.44 21.2 
12.
    42 F 2.52 4.1 5.1 71.4 1.3 3.09 2.42 10.3 
13.
    34 M 2.46 4.98 3.18 66.2 1.2 2.8 2.88 10.8 
14.
    34 F 2.1 3.7 4.44 74.5 1.82 2.2 3.4 18.2 
15.
    30 F 2.52 3.66 4.4 80.1 1.2 3.1 2.2 13.3 
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TABLE 3: MASTER CHART – GROUP I (LABORATORYPARAMETER) 
 
S. NO 
 
AGE 
 
SEX 
 
BASELINE SERUM ALBUMIL 
1.  37 F 4.8 
2.  39 M 4.7 
3.  41 M 4.8 
4.  33 F 4.9 
5.  37 F 4.9 
6.  48 M 4.9 
7.  48 M 4.9 
8.  32 M 4.6 
9.  38 F 4.8 
10.  47 M 4.9 
11 35 F 4.7 
12 30 M 4.9 
13 44 F 4.8 
14 33 M 4.7 
15 42 F 4.6 
 
 
Tables 
 
47 
 
TABLE 4: MASTER CHART – GROUP II (LABORATORYPARAMETER) 
 
S. NO 
 
AGE 
 
SEX 
 
BASELINE SERUM ALBUMIN 
 
3 MONTH POST-OP SERUM 
ALBUMIN 
1. 45 F 3.8 4.2 
2. 39 M 3.4                    3.8 
3. 41 M 3.8                     4.1 
4. 53 F 4.0 4.3 
5. 37 F 3.8                   4..0 
6. 45 M 3.9                  4..1 
7. 48 M 4.0 4..2 
8. 32 F 4.2 4.5 
9. 38 F 4.0 4.3 
10. 47 M 3.6 3.8 
11. 45 F 4.1 4.3 
12. 30 M 3.6 4.0 
13. 40 F 3.6 3.9 
14. 33 M 3.8 4.2 
15. 42 F 3.7 4.0 
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TABLE-5 
 
GROUP-I 
 
Descriptive Statistics 
 
 
 
Variables 
N Minimum Maximum Mean Std. 
Deviation 
Statistic Statistic Statistic Statistic Std. 
Error 
Statistic 
BASELINE PI 15 .45 .85 .644 .033 .131 
BASELINE  PPD 15 1.9 2.41 2.15 .041 .160 
BASELINE CAL 15 0 0 0 0 0 
BASELINE GBI 15 0 0 0 0 0 
BASELINE 
SERUM 
ALBUMIN 
15 4.36 5.01 4.73 .052 .203 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables 
 
49 
 
 
 
 
TABLE-6 
CORRELATION BETWEEN CLINICAL PARAMETERS AND SERUM 
ALBUMIN LEVEL IN GROUP 1 
 
CLINICAL PARAMETERS 
BASELINE  SERUM 
ALBUMIN 
BASELINE PI 
Pearson Correlation .245 
Sig. (2-tailed) .398 
BASELINE PPD 
Pearson Correlation .324 
Sig. (2-tailed) .258 
BASELINE CAL 
Pearson Correlation - 
Sig. (2-tailed) - 
BASELINE GBI 
Pearson Correlation - 
Sig. (2-tailed) - 
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TABLE-7 
GROUP 2 
 
Descriptive Statistics 
 
 
Variables 
N Minimum Maximum Mean Std. Deviation
Statistic Statistic Statistic Statistic Std. Error Statistic 
BASELINE PI 15 1.98 2.80 2.476 .065 .255
BASELINE PPD 15 3.66 7.12 5.174 .292 1.131
BASELINE CAL 15 2.42 6.98 5.024 .319 1.238
BASELINE GBI 15 51.20 91.30 74.820 3.022 11.707
BASELINE SERUM 
ALBUMIN 
15 3.65 4.32 3.956 .049 .192
3 MONTHS PI 15 .32 1.82 .984 .098 .380
3 MONTHS PPD 15 2.14 5.02 3.306 .210 .814
3 MONTHS CAL 15 2.33 5.22 3.454 .223 .866
3 MONTHS GBI 15 8.60 24.60 15.113 1.487 5.762
3 MONTHS SERUM 
ALBUMIN 
15 4.43 4.65 4.567 .017 .066
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TABLE-8 
CORRELATION BETWEEN CLINICAL PARAMETERS AND SERUM 
ALBUMIN LEVEL IN GROUP II 
CLINICAL PARAMETERS BASELINE SERUM 
ALBUMIN 
BASELINE PI 
Pearson Correlation -.098 
Sig. (2-tailed) .729 
BASELINE PPD 
Pearson Correlation -.117 
Sig. (2-tailed) .677 
BASELINE CAL 
Pearson Correlation -.061 
Sig. (2-tailed) .830 
BASELINE GBI 
Pearson Correlation -.015 
Sig. (2-tailed) .957 
 
CLINICAL PARAMETERS 
3 MONTHS SERUM 
ALBUMIN 
3 MONTHS PI 
Pearson Correlation .150 
Sig. (2-tailed) .595 
3 MONTHS PPD 
Pearson Correlation .246 
Sig. (2-tailed) .377 
3 MONTHS  CAL 
Pearson Correlation .212 
Sig. (2-tailed) .448 
3 MONTHS GBI 
Pearson Correlation .183 
Sig. (2-tailed) .515 
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TABLE-9 
CORRELATON BETWEEN CLINICAL PARAMETER AT BASE LINE & 
3 MONTHS IN GROUP II  
 
 
 
 
 
 
Paired T Test 
 
Variables Paired Differences t Df Sig. 
(2-
tailed)
Mean Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 
BASELINE PI 
- 3 MONTHS 
PI 
1.492 .457 .118 1.238 1.745 12.627 14 .000
Pair 2 
BASELINE 
PPD - 3 
MONTHS 
PPD 
1.868 .618 .159 1.526 2.210 11.710 14 .000
Pair 3 
BASELINE 
CAL - 3 
MONTHS 
CAL 
1.570 1.151 .297 .932 2.207 5.282 14 .000
Pair 4 
BASELINE 
GBI - 3 
MONTHS 
GBI 
59.706 11.273 2.910 53.463 65.949 20.511 14 .000
Pair 5 
BASELINE 
SERUM 
ALBUMIN - 3 
MONTHS 
SERUM 
ALBUMIN 
.611 .176 .045 .708 .513 13.386 14 .000
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TABLE-10 
 
UNPAIRED T TEST BETWEEN THE BASELINE SERUM ALBUMIN 
LEVEL OF HEALTHY PERIODONTIUM AND CHRONIC 
PERIODONTITIS 
 
 
 
Variables 
Differences T Df Sig. 
(2-
tailed) Mean Std. 
Error 
Mean 
95% Confidence 
Interval  
Lower Upper 
SERUM 
ALBUMIN 
LEVEL OF 
HEALTHY 
PERIODONTIUM 
vs. 
SERUM 
ALBUMIN 
LEVEL OF 
CHRONIC 
PERIODONTITIS 
 
 
 
 
 
.777 
 
 
 
 
 
.072 
 
 
 
 
 
.629 
 
 
 
 
 
.925 
 
 
 
 
 
10.745 
 
 
 
 
 
28 
 
 
 
 
 
.000 
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TABLE-11 
 
UNPAIRED T TEST BETWEEN THE BASELINE VALUES OF CLINICAL 
PARAMETERS OF CONTROL AND STUDY GROUP 
 
 
 
 
Variables 
Differences t Df Sig. (2-
tailed) 
Mean Std. 
Error 
Mean 
95% Confidence 
Interval  
Lower Upper 
CG PI BL - SG PI BL 
1.832       .074       1.680 1.984    24.725 28 .000 
CG PPD BL - SG PPD BL 
.340 .104        .127   .553 3.274 28 .001 
*CG – CONTROL GROUP, SG – STUDY GROUP, BL – BASELINE  
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Figure 1 : Comparison of plaque index between 
group I and  group II 
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Figure 2 : Comparison of  Probing pocket depth between 
group I and    group II 
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Figure 3 : Comparison of Clinical attachment level between 
group I and group II 
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Figure 4 : Comparison of gingival bleeding index 
between group I and group II 
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Figure 5: Comparison of serum albumin levels between 
group I and group II 
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                                              DISCUSSION 
Periodontitis is a chronic inflammatory disease caused by anerobic gram 
negative bacteria affecting the supporting structures of the teeth.  Serum Albumin 
concentration is a negative acute phase protein associated with inflammation and it 
might be a practical marker for general health status. Periodontitis results in the 
formation of many inflammatory mediators like   C -reactive proteins. Also this will 
stimulate antibody formation like IgG. A significant association between serum 
albumin concentration and IgG has been reported
 
.C -reactive protein may be used to 
identify the presence of inflammation in individuals with a lower serum albumin 
concentration.  
  Recently report says that the number of untreated teeth was a significant 
factor associated with serum albumin concentration in elderly. Therefore, it is 
suggestive that the oral disease burden might be monitored by the levels of serum 
albumin. 
             Inflammation and malnutrition both reduce the  serum albumin concentration 
by decreasing its rate of synthesis. This suggests that periodontal disease severity 
might be indicated and monitored by the levels of serum albumin. Therefore, serum 
albumin can be used as a risk predictor for periodontal disease.  
            The present study was carried out to estimate  the  levels of serum albumin at 
baseline level  and 3 months  after phase I therapy in patients with chronic 
periodontitis. 
      In the present study, 30 subjects were selected, among them  
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            15 subjects with clinically healthy individuals were categorized as- Group I 
(T0) and      
            15 subjects with generalized chronic Periodontitis were categorized as- Group 
II (T1). 
   Several studies have been carried out to evaluate albumin levels in serum in 
patients with chronic periodontitis but none of the studies were there to compare the 
serum albumin levels before and after phase 1 therapy in chronic periodontitis.  
 In the present study, subjects with any acute or chronic systemic conditions 
like diabetes or inflammatory conditions like rheumatoid arthritis, cardiovascular 
disease etc. have been excluded because these conditions can cause decreased 
albumin levels on their own, which may lead to confoundin g effect in the study. 
Smoking is also a potential confounding and environmental risk factor periodontitis 
and hence smokers were also excluded from the study. 
    Patients under medications like antibiotics, corticosteroids, anti-inflammatory 
drugs for past 3 months and those underwent periodontal therapy within past six 
months have been excluded because these therapies can suppress the inflammatory 
process and may lead to confounding effect in the study.    Patients under medications 
like antibiotics, corticosteroids, anti-inflammatory drugs for past 3 months and those 
underwent periodontal therapy within past six months have been excluded because 
these therapies can suppress the inflammatory process and may lead to confounding 
effect in the study. 
    Quantitative estimation of serum albumin levels done in the present study in 
both groups was done by   BROMOCRESOL GREEN method. 
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            In the present study, clinical parameters like plaque index, PPD, CAL, 
gingival bleeding index were also assessed and compared among the two groups to 
correlate with the levels of serum albumin to establish a relationship between altered 
serum albumin levels and periodontal disease status.  In present study PI and  PPD, 
Serum albumin  values at baseline in group I was (0.644 ± 0.033 2.15 ±0.041, 
4.73±0.052. ) respectively . 
         The mean base line value for PI, PPD, CAL, GBI and serum albumin was 
(2.476±0.065, 5.174±0.295, 5.024±0.319, 74.820±3.022 and 3.956± 0.49) and 3 
months value after phase I therapy was( 0.984± 0.098,3.306±0.210,3.454±0.223 
,15.113±1.487 and 4.567±0.0170) 
        The mean difference between the baseline values of PI, PPD,and  serum albumin 
was(1.832± 0.074, 0.340± 0.104 , 0.777 ± 0.072 ) which was found to be  statistically 
significant( p= 0.000)  . 
      And mean difference in PI ,PPD,CAL ,GBI  and serum albumin in Group II  at 
baseline  and 3 months post operative value was (1.492±0.118, 1.868 ±0.159, 
1.570±0.297 , 59.706±2.910, 0.611± 0.045  ) which was found to be statistically 
significant( p= 0.000)  . 
             The results of present study indicate the difference between serum albumin 
levels in Group I and Group II were found to be statistically significant (P ≤ 0.001). 
The findings of this clinical trial suggest an inverse relationship between the serum 
albumin concentration and chronic periodontal disease which is consistent with the 
finding of   Navkiran Kaur
40
 who done a study to evaluate the correlation of serum 
albumin levels with chronic periodontitis. 
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          The results observed from the present study shows  that the mean serum 
albumin levels in  patient with chronic periodontitis (3.65 ± 0..049) was significantly 
less than that in periodontally healthy subjects(4.73±0.052). And after three months of 
phase I therapy, the serum albumin levels increased significantly (4.43±0.017) and 
approached the levels in periodontally healthy subjects. And there was improvement 
in all the clinical parameters such as reduced BI, PI, PPD and gain in clinical 
attachment level. This finding might be attributed to a decrease in proinflammatory 
cytokine levels, especially IL-6, after periodontal intervention in patient with chronic 
periodontitis since IL-6 is the chief agent for the hepatocytic secretion of the majority 
of acute phase proteins. It appears logical that if periodontal inflammation decreases 
serum albumin levels, these levels should increase subsequent to non-surgical 
periodontal treatment which decreases the load of systemic inflammation        
        The results are consistent with Shirmohamadi et al
38
 who done a study to 
evaluate Effect of non-surgical periodontal treatment on transferrin serum levels in 
patients with chronic periodontitis. Serum Transferrin which is also a negative acute 
phase protein similar to that of albumin and results were  the mean transferrin serum 
level in patients with chronic periodontitis (213.1 ± 9.2 mg/dL) was significantly less 
than that in periodontally healthy subjects (307.8 ± 11.7 mg/dL). After three months 
periodontal trseatment, the transferrin serum level increased significantly (298.3 ± 7.6 
mg/dL) and approached the levels in periodontally healthy subjects (P < 0.05).   There 
is decrease in transferrin serum levels with periodontal disease and increased after 
periodontal treatment, respectively, indicated an inverse relationship between 
transferrin serum levels and chronic periodontitis. 
         In the present study the levels of serum albumin is low in all chronic 
periodonititis patients   which might be  consistence with the results reported   
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Kshirsagar et al
31  
 who studied levels of serum albumin and CRP among patients on 
HD. In this study, patients with severe periodontitis had low serum albumin levels 
(odds ratio 8.20; 95% confidence interval 1.61-41.82; p = 0.01) compared with 
individuals without severe periodontitis disease after and 3 months adjustment for 
several factors. 
   In a study by Pimpale S et al
76
 to correlate between periodontal disease and 
serum albumin concentration in chronic periodontitis patients and suggested that 
serum albumin concentration is an important risk indicator in chronic periodontitis 
patients. Thus, in present study it would seem appropriate to infer that the lower 
serum albumin concentrations were effected by inflammatory component  of  chronic 
periodontitis. 
 In a study done to evaluate the effect of Non-Surgical Periodontal Therapy on 
Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy suggest 
that hypoalbuminemia has been demonstrated to be a strong predictor of death in 
chronic renal failure. Some studies have however suggested that hypoalbuminemia 
may be more indicative of underlying inflammation, rather than nutritional status, 
especially in patients with kidney disease. Inflammation is an important predictor of 
low serum albumin levels among dialysis patients, independent of nutritional status. 
Low albumin is often indicative of malnutrition, but chronic inflammation appears to 
be the culprit in half of the patients with low levels of albumin. 
The above study were consistent with the present study suggesting that in 
which periodontitis   is also a chronic inflammatory condition in which low levels of 
serum albumin has been observed inferring that it might be a marker of inflammatory 
disease . 
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            The finding of our study shows statistically significant inverse relationship 
between serum albumin levels and chronic periodontal disease. Hence serum albumin 
levels might be an important risk indicator for chronic periodontal disease. In order to 
explore the actual cause to effect relationship between periodontal disease and serum 
albumin concentration, longitudinal evaluations with a larger population would be 
necessary. 
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                                          Summary and Conclusion 
            The present study was conducted in order to evaluate  the serum albumin  
levels  in chronic  periodontitis patients  before & after phase 1 therapy .A total of 30 
patients were selected  and  divided into two groups  Group I  - control group and 
Group II- chronic periodontitis. The clinical and laboratory data were assessed at 
baseline for control group and for chronic periodontitis patients at baseline and 3 
months after phase 1 therapy the values were subjected to statistical analysis.  
The following conclusions were drawn from the study: 
 Lower serum albumin levels were detected in patients with chronic 
periodontitis. 
 Non-surgical periodontal treatment resulted in an increase in serum albumin 
levels in chronic periodontitis group, which reached the levels in periodontally 
healthy subjects. 
Within the limits of the present study, it can be concluded that there is a statististically 
significant inverse association between serum albumin concentration and chronic 
periodontal disease.  Further studies are necessary with larger sample sizes to 
determine whether serum albumin levels can be used as diagnostic markers for 
periodontal diseases. In order to explore the actual cause to effect relationship 
between periodontal disease and serum albumin concentration, longitudinal 
evaluations with a larger population would be necessary. 
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Annexure 1: Participant Information Sheet- English 
PARTICIPANT INFORMATION SHEET 
TITLE OF THE STUDY: 
Estimation of serum albumin levels before and after phase I therapy in 
patients with chronic periodontitis.  
Assessment of effect of phase I periodontal therapy in altering serum albumin 
levels in patients with chronic Periodontitis. 
NAME OF THE RESEARCH INSTITUTION: 
Tamil Nadu Government Dental College and Hospital, Chennai. 
PURPOSE OF THE STUDY: 
The purpose of this study is to “Estimate Serum Albumin levels before and 
after phase I therapy in patients with chronic periodontitis”. 
PROCEDURE: 
Case history, Intra Oral examination X rays will be taken. About one table 
spoon of blood will be drawn from your hand. Scaling (cleaning of the teeth surface) 
and root planning will be done under Local anaesthesia. For some of the   participants 
the blood sample will be collected after 3months once again collected blood will be 
sent for estimation of serum albumin level. Clinical parameters such as gingival 
bleeding index, plaque index, probing pocket depth and clinical attachment level will 
be done. 
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RISK OF PARTICIPATION: 
       Pain, swelling can happen during blood sample collection.  
Radiation exposure during IOPA view radiographs procedure. 
Pain and discomfort due to local anaesthetic effect. 
BENEFITS OF PARTICIPATION: 
Patients get scaling and root planning therapy for periodontal disease. 
CONFIDENTIALITY: 
 The identity of the patients participating in the research will be kept 
confidential throughout the study. In the event of any publication and presentation 
resulting from the research, no personally identifiable information will be shared. 
PARTICIPANTS RIGHTS: 
  Taking part in the study is voluntary. You are free to decide whether to 
participate in the study or to withdraw at any time. Your decision will not result in 
any loss of benefits to which you are otherwise entitled. 
COMPENSATION :  Nil 
 
 
Name of the participant                   Signature of the participant 
 
For queries related to study: For queries related to rights of  participant              
xxxxxxxxxxxxxxx                                          xxxxxxxxxxxxxxxxx 
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Annexure 2: Informed Consent Form: English 
INFORMED CONSENT FORM 
 ESTIMATION OF SERUM ALBUMIN LEVELS BEFORE AND AFTER 
PHASE I THERAPY IN PATIENTS WITH CHRONIC PERIODONTITIS 
“I have read the foregoing information, or it has been read to me. I have had 
the opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction. I consent voluntarily to participate as a participant in this 
study and understand that I have the right to withdraw from the study at any time 
without in any way it affecting my further medical care.” 
 ________________        __________________________         
________________________ 
   Date   Name of the participant      Signature/Thumb impression 
         of the participant 
 
[The literate witness selected by the participant must sign the informed consent form. 
The witness should not have any relationship with the research team; If the 
participant does not want to disclose his/her participation details to others, in view of 
respecting the wishes of the participant, he/she can be allowed to waive from the 
witness procedure. (This is applicable to literate participant ONLY). This should be 
documented by the study staff by getting signature from the prospective participant.] 
 
 
“I have witnessed the accurate reading of the consent form to the potential 
participant and the individual has had opportunity to ask questions. I confirm that the 
individual has given consent freely.” 
 
           Date  Name of the witness            Signature of the witness 
 
 
 
          Date          Name of the interviewer         Signature of the interviewer 
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Annexure 3: Participant Information Sheet: Tamil 
                     
                  :              : 
       .  .                 .  .     
               
“                                                     
                                     ” 
      : 
             /                           : 
               -      ,        . 
                               . 
                                . 
                           2                    . 
                                0.5   2%           
                                                 
          .                                . 
                                                     
                .                                    . 
                            
                                         . 
                                 ,                
                            . 
                                      . 
                                                 . 
                         
                                                
              . 
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         : 
                                          
                    .                                 
                            . 
            : 
                                            
                                                 .       
                                                       
                      . 
 
 
 
 
                                     
__________________________________________________________________________________ 
                       :                                         
      : 
XXXXXXXXXXXXXXXXXXXX                        XXXXXXXXXXXXXXX 
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Annexure 4: Informed Consent Form: Tamil 
                 
            
“                                            
                                              ” 
 
     :          /    : 
     :              : 
            : 
                : 
 
     _______________________________     __________ 
                                                      
                             . 
 
                                    : 
                                                      
                
                                                  
                                                         
                                                           
       . 
                                                      
                       . 
                                                
          . 
                                                     
                      . 
 
 
 
_______________________________  _______________________  ___________ 
                                               
   
 
 
 
 
____________________________  _______________________  ___________ 
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Annexures 5: Proforma 
DEPARTMENT OF PERIODONTICS 
TAMILNADU GOVERNMENT DENTAL COLLEGE AND HOSPITAL 
CHENNAI – 600 003 
ESTIMATION OF SERUM ALBUMIN LEVELS BEFORE AND AFTER 
PHASE I THERAPY IN PATIENTS WITH CHRONIC PERIODONTITIS 
 
PROFORMA 
OP No:     DATE: 
NAME:     PATIENT ID No:    
AGE/SEX: 
ADDRESS:      
MOBILE No: 
OCCUPATION:     
INCOME: 
CHIEF COMPLAINT: 
HISTORY OF PERSENTING ILLNESS: 
 
PAST MEDICAL HISTORY: 
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PAST DENTAL HISTORY: 
 
HISTORY OF HABITS: 
 
INTRA ORAL EXAMINATION: 
1) No. of teeth present: 
2) Gingival examination 
Colour 
Contour 
Consistency 
Texture 
Position 
Pigmentation  
 
Mobility : 
 
Recession :  
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INVESTIGATIONS 
Blood Investigation: 
Hb count 
Total Leucocyte count 
Differential Leucocyte count 
Bleeding Time 
Clotting Time 
Random Blood Sugar 
 Serum albumin level 
SAMPLE BASELINE 3 MONTHS 
Serum albumin 
  
 
 
DIAGNOSIS 
 
PROGNOSIS 
 
TREATMENT 
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PHASE I: 
 
S.NO CALCULATIONS BASELINE 3 MONTHS 
1 Plaque index   
2 Gingival bleeding index   
3 Probing pocket depth   
4 Clinical attachment level   
5 Serum albumin   
 
 
SIGNATURE OF PG STUDENT SIGNATURE OF THE GUIDE                                
 
 
DATE 
 
 
 
 
 
 
 
 
 
